Yes - you can move a Malaysian drug registration from one holder to another without re-registering the product. NPRA's official procedure is the Change of Product Registration Holder (COH). The product keeps the same MA number, the outcome is decided within about 45 working days once the application is complete, and the registration must have at least 6 months of validity remaining. It needs the product owner's authorisation and the consent of the current holder - so if your contract secured transfer rights up front, changing your Marketing Authorisation Holder (MAH) is a defined administrative process, not a hostage negotiation.
A note on terms: NPRA officially calls the holder the "Product Registration Holder". Throughout RHMI's guides we use the equivalent international term, Marketing Authorisation Holder (MAH) - they mean the same party.
The nightmare scenario for a foreign manufacturer is simple: your product is selling in Malaysia, you want to change your local partner - and you discover the registration is in their name. Can you move it? Yes. NPRA has a formal transfer procedure, and it keeps your MA number. This guide explains how a change of MAH works, when you would use it, what it costs, and how to make sure you never need it as an emergency.
What a change of MAH (COH) is
Malaysia lets you transfer a registered product from one holder to another without re-registering it. NPRA's official name for this is the Change of Product Registration Holder (COH). Crucially, the product keeps the same registration - the MA number stays with the product, not the departing holder. The medicine's technical data, labelling and leaflet stay exactly the same; only the holder's name and address change. If you also want to change something about the product itself, that is a separate application.
When you would change your MAH
- Leaving a distributor who holds your registration - the classic lock-in situation we cover in Distributor as Your MAH in Malaysia.
- Moving to an independent MAH to regain neutral control of your registration (see MAH services in Malaysia).
- Corporate change - restructuring, a new local entity, or a merger or acquisition.
In every case the goal is the same: keep the product on the market, keep its registration, and move the holder role to the party you want.
The process and timeline
A change of holder runs roughly like this:
- Check validity first. The registration must have at least 6 months of validity remaining; if it has less, the current holder renews it before the transfer.
- The product owner issues a Letter of Authorization, appointing the new MAH and ending the current holder's authorisation.
- The current holder files the application through NPRA's QUEST system - the departing holder submits, not the incoming one - and pays the fee.
- NPRA evaluates. Once it deems the application complete, the Drug Control Authority decides within about 45 working days - the clock starts from a complete dossier, not the day you submit.
- On approval, the transfer takes effect - same MA number, remaining validity carried over. The previous holder's authorisation is then cancelled; a product cannot have two holders at once.
During the interim, the outgoing holder keeps responsibility, including pharmacovigilance, until the change is approved.
What it needs and what it costs
The core documents (per NPRA's DRGD, Appendix 31) are:
- A Letter of Authorization from the product owner, appointing the new MAH and ending the current holder's authorisation (notarised if the owner is a foreign company).
- Board resolutions of the parties consenting to the change.
- Company registration details of the new MAH - which must be a Malaysia-registered entity (SSM) and a registered QUEST user.
- A signed Statement of Acceptance by the new MAH (NPRA's form NPRA-430.5(3)).
Fee: RM 1,000 for a pharmaceutical product (RM 500 for a traditional product), non-refundable and paid on submission. Documents must be recent (generally not older than 6 months) and submitted as originals, and NPRA queries must be answered within 30 working days or the application can be rejected. Confirm the current document set and fees against NPRA's DRGD Appendix 31 before filing.
What if your current MAH won't cooperate?
This is the real fear behind most transfers, and it comes from one rule: the current holder files the application, not the incoming one. If your registration sits with a distributor who is slow, unwilling, or in dispute with you, the change needs their action - which is exactly what can feel like leverage against you.
It is rarely hopeless, but be realistic about what actually moves it:
- The product owner's authority is your leverage. The registration stands on your Letter of Authorization; the owner can withdraw the current holder's authority, which few holders want to be seen ignoring. Most standoffs settle commercially once that is on the table.
- Prepare the paperwork in parallel so that the moment cooperation comes, the filing is complete and nothing stalls.
- Worst case, re-register. If a holder truly refuses, the fallback is a fresh registration with a new MAH - slower and more costly than a change of holder, and a strong reason not to end up here in the first place.
How to avoid needing a rescue transfer
The smoothest change of MAH is the one you planned for. If your original MAH agreement secured your dossier ownership and transfer rights, a change of holder is a routine administrative step. If it did not - if a distributor holds your registration and has no obligation to release it - you may need their cooperation at exactly the moment the relationship has soured. The lesson is simple: choose an independent MAH and lock in transfer rights from day one.
You can move your Malaysian registration to a new MAH via NPRA's Change of Product Registration Holder (COH), keeping the same MA number - and it is easiest when your contract secured transfer rights up front.
Frequently asked questions
Can I transfer my Malaysian drug registration to a new holder?
Yes. NPRA's Change of Product Registration Holder (COH) procedure lets you move a registered product from one holder to another without re-registering it, and the product keeps the same MA number.
How long does a change of MAH take in Malaysia?
The Drug Control Authority decides within about 45 working days once NPRA deems the application complete - so the clock starts from a complete dossier, not from the day you submit.
Do I need the current holder's consent to change the MAH?
Yes. The process needs a Letter of Authorization from the product owner and the consent (board resolutions) of the parties. This is why it matters to secure transfer rights in your MAH agreement from the start.
What if my current MAH refuses to cooperate?
Because the current holder has to file the change, a refusal can stall a transfer. Your leverage is the product owner's authorisation - the owner can withdraw the holder's authority, and most standoffs settle commercially once it does. If a holder truly refuses, the fallback is a fresh registration with a new MAH, which is slower and costlier - the reason to secure transfer rights up front.
Does my product change during a change of holder?
No. The product's technical data, labelling and leaflet stay the same; only the holder's name and address change. Any change to the product itself is a separate application.
What does a change of holder cost in Malaysia?
NPRA's fee is RM 1,000 for a pharmaceutical product (RM 500 for a traditional product), non-refundable and paid on submission, plus your own advisory and administrative costs. Confirm current fees against NPRA's guidance before filing.
You might also find useful
- Marketing Authorisation Holder (MAH) in Malaysia: What It Is and How to Appoint One
- Distributor as Your MAH in Malaysia: Lock-in Risk and How to Keep Control
- Sources:
- NPRA - Change of Product Registration Holder (COH): npra.gov.my (COH)
- NPRA Drug Registration Guidance Document (DRGD), Appendix 31 - Change of Product Registration Holder: npra.gov.my
- Editorial note: This article is general business and regulatory information for manufacturers evaluating Malaysia. It is not legal or regulatory advice. Timelines, fees and document requirements are administrative details that change; confirm them against NPRA's current DRGD (Appendix 31) before acting.